Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,405
Out of 5,008 analysts
55
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $133.02 | -9.79% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $76.72 | +69.45% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $67.73 | +62.41% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $6.46 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $66.03 | -52.67% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $16.90 | +107.10% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $126.89 | +132.48% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $52.15 | +74.50% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $51.84 | -47.92% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $313.45 | -78.62% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $133.02
Upside: -9.79%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $76.72
Upside: +69.45%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $67.73
Upside: +62.41%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $6.46
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $66.03
Upside: -52.67%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $16.90
Upside: +107.10%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $126.89
Upside: +132.48%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $52.15
Upside: +74.50%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $51.84
Upside: -47.92%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $313.45
Upside: -78.62%